The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

The Food and Drug Administration's top ... Prasad noted that Marks sidelined Office of Vaccines Research Research and Review leaders in 2021 for resisting rushed full approval of COVID vaccines and ...

(CNN) — The US Food and Drug Administration has named Dr. Vinay Prasad ... the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments. Marks resigned from the agency in March ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

recently announced a new vaccine program, which will aid in developing shots for pandemic-prone viruses. A target of 2029 was set for initial FDA approval, potentially under Prasad's leadership ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the health agency’s program for vaccines and biotech drugs.